Goldman Sachs Group Inc Vigil Neuroscience, Inc. Transaction History
Goldman Sachs Group Inc
- $596 Billion
- Q1 2025
A detailed history of Goldman Sachs Group Inc transactions in Vigil Neuroscience, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 55,566 shares of VIGL stock, worth $437,860. This represents 0.0% of its overall portfolio holdings.
Number of Shares
55,566
Previous 55,566
-0.0%
Holding current value
$437,860
Previous $98,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding VIGL
# of Institutions
52Shares Held
29.3MCall Options Held
0Put Options Held
0-
Atlas Venture Life Science Advisors, LLC5.84MShares$46 Million3.04% of portfolio
-
Northpond Ventures, LLC4.21MShares$33.2 Million51.65% of portfolio
-
Bvf Inc San Francisco, CA4.01MShares$31.6 Million0.31% of portfolio
-
Siren, L.L.C. New York, NY1.97MShares$15.5 Million0.2% of portfolio
-
683 Capital Management, LLC New York, NY1.74MShares$13.7 Million0.25% of portfolio
About Vigil Neuroscience, Inc.
- Ticker VIGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,268,600
- Market Cap $223M
- Description
- Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases. Its lead product candidate is VGL101, a fully human monoclonal antibody (mAb) that is designed to activate triggering receptor expressed...